STRAGEN NORDIC A/S: Financial statements 2020
CVR: 26717825
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 6,764,350 and a net result of DKK 2,602,117 compared with DKK 1,741,348 the year before. That is a decrease of 3.7% compared with the year before. Equity in the 2020 report amounted to DKK 9,712,058. The solvency ratio was 42.3%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 6,764,350
- Profit/Loss
- DKK 2,602,117
- Equity
- DKK 9,712,058
- Total Assets
- DKK 22,965,213
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 6.8M | 2.6M | 9.7M | 6 |
| 2019 | - | 7M | 1.7M | 7.1M | 6 |
| 2018 | - | 5.5M | 1.9M | 5.4M | - |
| 2017 | - | 4.1M | 497K | 3.5M | - |
| 2016 | - | 4.2M | 702K | 3.3M | - |
Official annual report
How creditworthy is STRAGEN NORDIC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
STRAGEN NORDIC A/S has published its annual report for 2019. Gross profit came to DKK 7,024,337, and the net result was DKK 1,741,348.
As of April 30, 2020, Jean-Baptiste Pierre Marie Amadieu has joined the board of directors of STRAGEN NORDIC A/S.
As of April 30, 2020, Antoine Tétard has left the board of directors of STRAGEN NORDIC A/S.
About STRAGEN NORDIC A/S
STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.
